Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C T Geijteman

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Heart Failure|December 22, 2017
Denying the inevitability of deathEric C T Geijteman
JAMA Internal Medicine|October 6, 2015
Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting IllnessEric C T Geijteman, Henning Tiemeier, Teun van Gelder
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2018
[A man with a black oesophagus]G J Boersen, Eric C T Geijteman, Dave H Schweitzer
JAMA Internal Medicine|January 27, 2015
Sense and nonsense of treatment of comorbid diseases in terminally ill patientsEric C T Geijteman, Teun van Gelder, Lia van Zuylen
Nederlands Tijdschrift Voor Geneeskunde|July 25, 2018
[A man who was unable to open his eyes]Wala Al Arashi, Eric C T Geijteman, Dave H Schweitzer
Annals of Internal Medicine|December 14, 2020
Universal Do-Not-Resuscitate Orders, Social Worth, and Life-YearsEric C T Geijteman, Frank H Bosch, Yvo M Smulders
Nederlands Tijdschrift Voor Geneeskunde|April 29, 2026
[The blind spot in oncological care; disease scenarios as a foundation for careful decision-making]Evelien J M Kuip, Eric C T Geijteman, Hans M Westgeest
Nederlands Tijdschrift Voor Geneeskunde|September 12, 2013
[10 years after implementation of the Liverpool Care Pathway for the dying patient; important improvements in end-of-life care]Eric C T Geijteman, Anneke G W M Dekkers, Lia van Zuylen
Obstetrics and Gynecology|July 9, 2014
A child with severe hearing loss associated with maternal cisplatin treatment during pregnancyEric C T Geijteman, Celesta W M Wensveen, Johannes J Duvekot, et al.
Journal of Pain and Symptom Management|January 21, 2019
Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later"Harriette J van Esch, Eric C T Geijteman, Carin C D van der Rijt
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Heart Failure|December 22, 2017
Denying the inevitability of deathEric C T Geijteman
JAMA Internal Medicine|October 6, 2015
Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting IllnessEric C T Geijteman, Henning Tiemeier, Teun van Gelder
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2018
[A man with a black oesophagus]G J Boersen, Eric C T Geijteman, Dave H Schweitzer
JAMA Internal Medicine|January 27, 2015
Sense and nonsense of treatment of comorbid diseases in terminally ill patientsEric C T Geijteman, Teun van Gelder, Lia van Zuylen
Nederlands Tijdschrift Voor Geneeskunde|July 25, 2018
[A man who was unable to open his eyes]Wala Al Arashi, Eric C T Geijteman, Dave H Schweitzer
Annals of Internal Medicine|December 14, 2020
Universal Do-Not-Resuscitate Orders, Social Worth, and Life-YearsEric C T Geijteman, Frank H Bosch, Yvo M Smulders
Nederlands Tijdschrift Voor Geneeskunde|April 29, 2026
[The blind spot in oncological care; disease scenarios as a foundation for careful decision-making]Evelien J M Kuip, Eric C T Geijteman, Hans M Westgeest
Nederlands Tijdschrift Voor Geneeskunde|September 12, 2013
[10 years after implementation of the Liverpool Care Pathway for the dying patient; important improvements in end-of-life care]Eric C T Geijteman, Anneke G W M Dekkers, Lia van Zuylen
Obstetrics and Gynecology|July 9, 2014
A child with severe hearing loss associated with maternal cisplatin treatment during pregnancyEric C T Geijteman, Celesta W M Wensveen, Johannes J Duvekot, et al.
Journal of Pain and Symptom Management|January 21, 2019
Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later"Harriette J van Esch, Eric C T Geijteman, Carin C D van der Rijt
Pageof 5